N-(3-(7-(3-Amino-4-methylphenylamino)-1-methyl-2-oxo-1,2-dihydropyrimido[4,5-d]pyrimidin-3(4H)-yl)-4-methylphenyl)-biphenyl-3-carboxamide

ID: ALA3780978

Chembl Id: CHEMBL3780978

PubChem CID: 127031123

Max Phase: Preclinical

Molecular Formula: C34H31N7O2

Molecular Weight: 569.67

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(-c5ccccc5)c4)ccc2C)C3)cc1N

Standard InChI:  InChI=1S/C34H31N7O2/c1-21-12-14-27(17-29(21)35)38-33-36-19-26-20-41(34(43)40(3)31(26)39-33)30-18-28(15-13-22(30)2)37-32(42)25-11-7-10-24(16-25)23-8-5-4-6-9-23/h4-19H,20,35H2,1-3H3,(H,37,42)(H,36,38,39)

Standard InChI Key:  APTIEAJHDWJGSB-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3780978

    ---

Associated Targets(Human)

K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Bcr/Abl fusion protein (1667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Transcription factor ETV6/Tyrosine-protein kinase ABL1 (41 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 569.67Molecular Weight (Monoisotopic): 569.2539AlogP: 6.91#Rotatable Bonds: 6
Polar Surface Area: 116.48Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.55CX Basic pKa: 4.12CX LogP: 6.32CX LogD: 6.32
Aromatic Rings: 5Heavy Atoms: 43QED Weighted: 0.19Np Likeness Score: -1.24

References

1. Liang X, Liu X, Wang B, Zou F, Wang A, Qi S, Chen C, Zhao Z, Wang W, Qi Z, Lv F, Hu Z, Wang L, Zhang S, Liu Q, Liu J..  (2016)  Discovery of 2-((3-Amino-4-methylphenyl)amino)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-ABL-053) as a Potent, Selective, and Orally Available BCR-ABL/SRC/p38 Kinase Inhibitor for Chronic Myeloid Leukemia.,  59  (5): [PMID:26789553] [10.1021/acs.jmedchem.5b01618]

Source